159.9K XNAS Volume
XNAS 02 Apr, 2025 12:06 PM (EDT)
CryoPort Inc Key Metrics
Default
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Check Before You Buy
VIEW FULL CHECKLISTLow rank
4Positive15Negative
21.1% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
CryoPort Inc Stock Price Analysis
Day Price Range | 6.2 (LTP) 5.86.3 LowHigh |
Week Price Range | 6.2 (LTP) 5.87 LowHigh |
Month Price Range | 6.2 (LTP) 4.67.2 LowHigh |
52 Week Price Range | 6.2 (LTP) 4.620.1 LowHigh |
CryoPort Inc Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
CryoPort Inc's Revenue was higher than average estimate 2 times in past 3 years
EPS forecast
Current EPS
Avg. Estimate
Hit
EPS is expected to grow by 54.6% in FY25
Consensus Recommendation
9 ANALYST Recommendations
BUY
The consensus recommendation from 9 analysts for CryoPort Inc is BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get CryoPort Inc Stock Analysis
CryoPort Inc stock analysis with key metrics, changes, and trends.
CryoPort Inc Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $228.38 M | 2.09% | negative |
| |
Annual Net Profit | $114.76 M | 15.23% | negative |
| |
Price to Earning Ratio | -2.71 | - | negative |
| |
Stock Price | $6.22 | -65.69% | negative |
| |
Quarterly Revenue | $59.53 M | 3.97% | positive |
| |
Quarterly Net profit | $18.68 M | 70.06% | positive |
| |
Mutual Fund Holding | 49.37 % | -0.05% | negative |
| |
Promoter Share Holding | 3.51 % | 0.11% | positive |
| |
Institutional Holding | 95.35 % | 0% | neutral |
|
Loading data..
CryoPort Inc - Company Profile
What does CryoPort Inc do?
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
CryoPort Inc Management structure
All Gross Remunerations are in USD
CryoPort Inc Board of directors
All Gross Remunerations are in USD